ข่าวประชาสัมพันธ์ Press Releases ข่าวย้อนหลัง หัวข้อข่าว บลอก

วันพฤหัสบดีที่ ๒ ตุลาคม พ.ศ. ๒๕๕๗ ๑๙:๒๗ น.

Food and Healthcare Press Releases

DMG Books and D Academy in order to reveal their approach to spiritual healing and case studies from around the world. Heathcare—๒๙ ก.ย. ๕๗

Alexander and Carolin Toskar, the spiritual healers and authors of Divine Straightening and Health as a Path, are coming to Thailand again to host the Spiritual Healing Meditations for Everyday Life activity in collaboration with DMG Books and D Academy

Pfizer Shines Spotlight on Stroke Threat on World Heart Day 2014 Heathcare—๒๘ ก.ย. ๕๗

To mark 2014 World Heart Day, which takes place on 29th September 2014, Pfizer (Thailand) Limited, one of Thailand’s largest research-based biopharmaceutical companies, has brought to light the growing threat of cardiovascular diseases (CVD). Now

Photo Release: Asian manufacturers to bring new Rabies vaccine Heathcare—๒๘ ก.ย. ๕๗

BioNet-Asia Co., Ltd. led by Mr. Vitoon Vonghangool (2nd from right), Managing Director, recently organized a MOU Signing Ceremony on the Collaboration in Manufacturing Rabies Vaccine in Thailand with Queen Saovabha Memorial Institute (QSMI) of the Thai

Blackmores and Boots join together for Time Never Stopscampaign Heathcare—๑ ต.ค. ๕๗

Blackmores (Thailand) Ltd., a leading brand of dietarysupplements in Australia, joined forces with Boots Retail (Thailand) Ltd., a pharmacy-led health and beauty retailer from the UK, to organize the “Time Never Stops by Blackmores” campaign.

SIR-Spheres(R) y-90 Resin Microspheres Recommended in New European Society of Medical Oncology Heathcare—๑ ต.ค. ๕๗

Newly published European Society for Medical Oncology (ESMO) clinical guidelines for the treatment of metastatic colorectal cancer (mCRC) endorse radioembolisation, specifically with Yttrium-90 resin microspheres, as a clinically proven technology to

Occlutech Obtains European CE Approval for its Dedicated Paravalvular Leak Closure Heathcare—๓๐ ก.ย. ๕๗

Occlutech, a leading innovator of products to treat structural heart disease today announced that it has obtained a European CE Mark approval for its dedicated Paravalvular Leak Closure Device, (PLD). The implant is the world's first, specifically

Merck Serono Awards EUR1 Million to the Winners of the First Grant for Oncology Heathcare—๒๙ ก.ย. ๕๗

- Global winners selected for their unique research projects that have the potential to advance research for the personalized treatment of solid tumors - Winners chosen by a Scientific Steering Committee comprising internationally renowned oncologists

Boehringer Ingelheim#s afatinib Achieves Primary Endpoint in Global Phase III Study in Heathcare—๒๙ ก.ย. ๕๗

- Results from the LUX-Head & Neck 1 study show afatinib* significantly delayed tumour growth versus chemotherapy in patients following failure of their previous treatment, reducing the risk for disease progression by 20% - Head and neck cancer has a

Putting the Patient First: Merck Serono to Present Data That Embodies the ESMO 2014 Theme of Heathcare—๒๖ ก.ย. ๕๗

ESMO 2014 Abstract #: Physician biomarker survey: 1080O_PR; Erbitux: CRYSTAL: 541P; LASCCHN: 993PD; DIRECT: 996P; Pipeline: pimasertib: 443O; c-Met: 1333TiP, 450PD, 744TiP, 745TiP; further pipeline: 772P, 507PD, 1235P - New research evaluates

World Heart Federation Announces a Donation from Bristol-Myers Squibb and Pfizer for a Program to Heathcare—๒๕ ก.ย. ๕๗

AF is the most common type of heart arrhythmia in the world, responsible for 15 - 20 per cent of strokes which affect the brain The World Heart Federation (WHF) is delighted to announce a charitable donation from the pharmaceutical companies

Unisense FertiliTech A/S Receives FDA Clearance for Tool to Aid in Embryo Selection to Improve IVF Heathcare—๒๕ ก.ย. ๕๗

Customized embryo evaluation tools for IVF practices now available for clinical use in the USA World leading time-lapse technology provider within the field of IVF, Unisense FertiliTech A/S, has received FDA 510(k) clearance for its "Compare &

Coherus BioSciences Appoints Mary Szela to Board of Directors Heathcare—๒๕ ก.ย. ๕๗

Coherus BioSciences, Inc., a late-stage biologics platform company focused on the global biosimilar market, announced today the appointment of Mary Szela, Chief Executive Officer of Melinta Therapeutics, Inc., to its board of directors. "We are

International Federation on Ageing and Bayer HealthCare Release Report Raising Awareness of How Heathcare—๒๕ ก.ย. ๕๗

- The first-of-its-kind report investigates how pets may contribute to physical, mental and societal well-being, in an ageing global demographic With advances in global public health, people around the world are living longer than ever before[i]. In

Fight the Fat Off with APEX Profound Beauty Heathcare—๒๓ ก.ย. ๕๗

To mark its 20th anniversary celebration, Apex Profound Beauty, a world class Aesthetic center for skin & body and the most advanced innovation to the best body shape organizes ‘Fight the Fat Off’ competition for public interests to deal

ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Heathcare—๒๒ ก.ย. ๕๗

Reductions in kidney failure obtained during intensive glucose control persist for many years in people with diabetes type 2 "Intensive treatment is likely to produce major long term benefits for the kidneys." Australian researchers have discovered

Blood Pressure Treatment Benefits on Survival Persist for Years - New Findings in Patients with Heathcare—๒๒ ก.ย. ๕๗

Australian researchers have discovered that the reductions in heart events and death, from using blood pressure-lowering drugs in patients with type 2 diabetes, persist for many years after treatment has stopped. The global study has found that, six

New Xultophy(R) (IDegLira) Data Show Rapid and Predictable Glycaemic Improvements in People with Heathcare—๒๒ ก.ย. ๕๗

Analyses of DUAL(TM) trial data compared Xultophy(R) (IDegLira)to insulin degludec and liraglutide alone in both insulin-naïve and insulin-treated patients New analyses of phase 3a DUAL(TM) clinical data show that adults with type 2 diabetes

Merck Serono Awards Grant for Growth Innovation (GGI) for the First Heathcare—๑๙ ก.ย. ๕๗

- The first grants awarded to coincide with the 53rd European Society for Paediatric Endocrinology (ESPE) Meeting - Investment supports innovative projects for the advancement of science and medical research in the field of growth Merck Serono, the

3D Systems Introduces New Simbionix Robotics Training Platform Heathcare—๑๙ ก.ย. ๕๗

- New Simbionix RobotiX Mentor(TM) is the only hands-on, complete procedural training simulator for robotic surgery skills - Company demonstrates new module at European Association of Urology (EAU) Robotic Urology Section (ERUS) 3D Systems (NYSE:DDD)

Merck Strengthens Executive Board Heathcare—๑๙ ก.ย. ๕๗

Merck today announced that the Board of Partners has promoted Stefan Oschmann (57) to the position of Deputy CEO and Vice Chairman of the Executive Board. Concurrently, Belen Garijo (54) was appointed to the Executive Board to take over leadership for

Asian manufacturers to bring new Rabies vaccine Heathcare—๑๘ ก.ย. ๕๗

Queen Saovabha Memorial Institute, BioNet-Asia and Liaoning Cheng Da Biotechnology jointly announce a collaboration to manufacture the next generation Rabies vaccine in Thailand. The rabies vaccine manufacturing collaboration was signed today between

Hetero Enters License Agreement With Gilead Sciences Inc., USA to Produce Generic Sofosbuvir for Heathcare—๑๗ ก.ย. ๕๗

Hetero Group, today announced that it has obtained licensing rights to manufacture and market sofosbuvir and combination drug ledipasvir/sofosbuvir upon approval from Gilead Sciences Inc., USA for 90 countries. Under the said agreement, Hetero is

World Sepsis Day September 13th, 2014: Death from Ebola Sepsis in West Africa and 8 Million Sepsis Heathcare—๑๖ ก.ย. ๕๗

The current outbreak of the Ebola virus is unprecedented. The Global Sepsis Alliance fully supports the call of WHO's Secretary General M. Chan that the international community will need to gear up its support. The Ebola virus is one of hundreds of

Paul G. Allen Backs Two New Initiatives in the Fight Against the Ebola Heathcare—๑๖ ก.ย. ๕๗

-- Initiatives will provide 50,000 health kits to affected areas and facilitate flights to deliver essential supplies Philanthropist Paul G. Allen announced today two new initiatives as part of a comprehensive relief campaign to provide resources and